Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation-Reference-Cited by-同舟云学术

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

Published:2018-03-25 Issue:4 Volume:143 Page:746-757
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Abubakar Mustapha¹²^ORCID,Chang-Claude Jenny³⁴,Ali H. Raza⁵,Chatterjee Nilanjan⁶⁷,Coulson Penny²,Daley Frances⁸,Blows Fiona⁹,Benitez Javier¹⁰¹¹^ORCID,Milne Roger L.¹²¹³,Brenner Hermann¹⁴¹⁵¹⁶,Stegmaier Christa¹⁷,Mannermaa Arto¹⁸¹⁹,Rudolph Anja³,Sinn Peter²⁰,Couch Fergus J.²¹,Devilee Peter²²,Tollenaar Rob A.E.M.²³,Seynaeve Caroline²⁴,Figueroa Jonine²⁵,Lissowska Jolanta²⁶,Hewitt Stephen²⁷,Hooning Maartje J.²⁴,Hollestelle Antoinette²⁴,Foekens Renée²⁴,Koppert Linetta B.²⁸,Investigators kConFab²⁹³⁰,Bolla Manjeet K.³¹,Wang Qin³¹,Jones Michael E.²,Schoemaker Minouk J.²,Keeman Renske³²,Easton Douglas F.⁹³¹,Swerdlow Anthony J.²³³,Sherman Mark E.³⁴,Schmidt Marjanka K.³¹³⁵,Pharoah Paul D.⁹³¹,Garcia-Closas Montserrat¹

Affiliation:

1. Division of Cancer Epidemiology and Genetics; National Cancer Institute, National Institutes of Health; Rockville MD

2. Division of Genetics and Epidemiology; The Institute of Cancer Research; London United Kingdom

3. Division of Cancer Epidemiology; German Cancer Research Center (DKFZ); Heidelberg Germany

4. University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf; Hamburg Germany

5. Cancer Research UK Cambridge Institute, University of Cambridge; Cambridge United Kingdom

6. Department of Biostatistics; Bloomberg School of Public Health, Johns Hopkins University; Baltimore MD

7. Department of Oncology, School of Medicine, Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University; Baltimore MD

8. Division of Breast Cancer Research, Breast Cancer Now Toby Robins Research Centre; The Institute of Cancer Research; London United Kingdom

9. Department of Oncology, Centre for Cancer Genetic Epidemiology; University of Cambridge; Cambridge United Kingdom

10. Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO); Madrid Spain

11. Centro de Investigacion en Red de Enfermedades Raras (CIBERER); Valencia Spain

12. Cancer Epidemiology Centre, Cancer Council Victoria; Melbourne VIC Australia

13. Melbourne School of Population and Global Health, Centre for Epidemiology and Biostatistics; The University of Melbourne; Melbourne VIC Australia

14. Division of Clinical Epidemiology and Aging Research; German Cancer Research Center (DKFZ); Heidelberg Germany

15. Division of Preventive Oncology; German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT); Heidelberg Germany

16. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ); Heidelberg Germany

17. Saarland Cancer Registry; Saarland Germany

18. School of Medicine; Institute of Clinical Medicine, Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland; Kuopio Finland

19. Department of Clinical Pathology, Imaging Center; Kuopio University Hospital; Kuopio Finland

20. Department of Pathology; Institute of Pathology, Heidelberg University Hospital; Heidelberg Germany

21. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN

22. Department of Human Genetics & Department of Pathology; Leiden University Medical Center; Leiden The Netherlands

23. Department of Surgery; Leiden University Medical Center; Leiden The Netherlands

24. Department of Medical Oncology; Family Cancer Clinic, Erasmus MC Cancer Institute; Rotterdam The Netherlands

25. Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh; Scotland United Kingdom

26. Department of Cancer Epidemiology and Prevention; M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology; Warsaw Poland

27. Laboratory of Pathology; National Cancer Institute, National Institutes of Health; Rockville MD

28. Department of Surgical Oncology; Erasmus MC Cancer Institute; Rotterdam The Netherlands

29. Research Department; Peter MacCallum Cancer Centre; Melbourne VIC Australia

30. The Sir Peter MacCallum Department of Oncology University of Melbourne, Parkville; Melbourne VIC Australia

31. Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology; University of Cambridge; Cambridge United Kingdom

32. Division of Molecular Pathology; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital; Amsterdam The Netherlands

33. Division of Breast Cancer Research; The Institute of Cancer Research; London United Kingdom

34. Division of Epidemiology, Department of Health Sciences Research; Mayo Clinic; Jacksonville FL

35. Division of Psychosocial Research and Epidemiology; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital; Amsterdam The Netherlands

Funder

Baden Württemberg Ministry of Science, Research and Arts

The German Cancer Aid

Government Funding (EVO) of Kuopio University Hospital

Cancer Fund of North Savo

Finnish Cancer Organizations

The Academy of Finland and by the strategic funding of the University of Eastern Finland

Deutsche Krebshilfe

The Hamburg Cancer Society

Deutsches Krebsforschungszentrum

The Federal Ministry of Education and Research (BMBF) Germany

National Institutes of Health Specialized Program of Research Excellence (SPORE) in Breast Cancer

The Breast Cancer Research Foundation

The Mayo Clinic Breast Cancer Registry and a generous gift from the David F. and Margaret T. Grohne Family Foundation

The Ting Tsung and Wei Fong Chao Foundation

Dutch Cancer Society

The Biobanking and Biomolecular Resources Research Infrastructure

Cancer Research UK

UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge

European Community's Seventh Framework Programme

Breakthrough Breast Cancer

The Institute of Cancer Research, London

Intramural Research Funds of the National Cancer Institute, Division of Cancer Epidemiology and Genetics, National Institutes of Health, USA.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31352/fullpdf

Reference52 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland;Spitale;Ann Oncol,2009

3. Insight into the heterogeneity of breast cancer through next-generation sequencing;Russnes;J Clin Invest,2011

4. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status;Howlader;J Natl Cancer Inst,2014

5. Race, breast cancer subtypes, and survival in the carolina breast cancer study;Carey;JAMA,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for breast cancer subtypes by race and ethnicity: a scoping review;JNCI: Journal of the National Cancer Institute;2024-07-17

2. Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literature;2024-03-19

3. Assessment of the Attitudes, Beliefs, and Potential Effects of Nutritional Phytoestrogenic Plant Consumption on Women’s Health in Saudi Arabia;Cureus;2023-06-25

4. Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health Study;2023-04-14

5. Menopause hormone treatment after cancer;Climacteric;2023-04-03